HomeCompareRHNMF vs PLD

RHNMF vs PLD: Dividend Comparison 2026

RHNMF yields 10526.32% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RHNMF wins by $91421458538285344.00M in total portfolio value
10 years
RHNMF
RHNMF
● Live price
10526.32%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$91421458538285344.00M
Annual income
$89,744,322,218,307,970,000,000.00
Full RHNMF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — RHNMF vs PLD

📍 RHNMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHNMFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHNMF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHNMF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHNMF
Annual income on $10K today (after 15% tax)
$894,736.84/yr
After 10yr DRIP, annual income (after tax)
$76,282,673,885,561,770,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, RHNMF beats the other by $76,282,673,885,561,770,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHNMF + PLD for your $10,000?

RHNMF: 50%PLD: 50%
100% PLD50/50100% RHNMF
Portfolio after 10yr
$45710729269142672.00M
Annual income
$44,872,161,109,153,986,000,000.00/yr
Blended yield
98.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

RHNMF
No analyst data
Altman Z
-9.5
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHNMF buys
0
PLD buys
0
No recent congressional trades found for RHNMF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHNMFPLD
Forward yield10526.32%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$91421458538285344.00M$5.91M
Annual income after 10y$89,744,322,218,307,970,000,000.00$4,750,725.19
Total dividends collected$91309952364754128.00M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RHNMF vs PLD ($10,000, DRIP)

YearRHNMF PortfolioRHNMF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$1,063,332$1,052,631.58$11,241$540.96+$1.05MRHNMF
2$105,744,905$104,607,140.08$13,019$991.13+$105.73MRHNMF
3$9,835,430,757$9,722,283,708.79$15,801$1,870.97+$9835.41MRHNMF
4$855,644,041,989$845,120,131,078.84$20,609$3,701.21+$855644.02MRHNMF
5$69,627,827,846,009$68,712,288,721,080.95$29,919$7,867.97+$69627827.82MRHNMF
6$5,300,152,192,813,391$5,225,650,417,018,161.00$50,631$18,617.74+$5300152192.76MRHNMF
7$377,430,657,448,967,200$371,759,494,602,656,830.00$105,528$51,352.20+$377430657448.86MRHNMF
8$25,145,413,383,015,215,000$24,741,562,579,544,820,000.00$287,364$174,449.42+$25145413383014.93MRHNMF
9$1,567,417,121,474,185,500,000$1,540,511,529,154,359,300,000.00$1,081,760$774,280.77+$1567417121474184.50MRHNMF
10$91,421,458,538,285,340,000,000$89,744,322,218,307,970,000,000.00$5,908,209$4,750,725.19+$91421458538285344.00MRHNMF

RHNMF vs PLD: Complete Analysis 2026

RHNMFStock

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is headquartered in Cremorne, Australia.

Full RHNMF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this RHNMF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHNMF vs SCHDRHNMF vs JEPIRHNMF vs ORHNMF vs KORHNMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.